Literature DB >> 20637012

Neurocognitive dysfunction and psychosocial outcome in patients with bipolar I disorder at 15-year follow-up.

K E Burdick1, J F Goldberg, M Harrow.   

Abstract

OBJECTIVE: Despite increasing interest in cognitive dysfunction in bipolar disorder, little is known about its impact on functional outcome relative to affective symptoms.
METHOD: A total of 33 bipolar I subjects were evaluated at index hospitalization and prospectively followed up 15 years later. Affective symptoms, cognition, global functioning, work, and social adjustment were assessed at follow-up and analyzed by linear regression.
RESULTS: Global functional impairment was significantly associated with poor performance on a cognitive measure of processing speed (WAIS Digit Symbol). Digit symbol performance also was the sole significant predictor of social functioning. Neither symptom severity nor course of illness features significantly contributed to global and social functioning. In contrast, verbal learning deficits, recent depression, and lifetime hospitalizations all were independently associated with work disability.
CONCLUSION: Processing speed is robustly associated with social and global functioning in bipolar disorder. Poor work functioning is significantly related to subsyndromal depression, course of illness, and verbal learning deficits. Cognitive and mood symptoms warrant consideration as independent determinants of functioning in patients with bipolar disorder many years after an index manic episode.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2010        PMID: 20637012      PMCID: PMC2980854          DOI: 10.1111/j.1600-0447.2010.01590.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  32 in total

1.  The prediction of outcome in schizophrenia. I. Characteristics of outcome.

Authors:  J S Strauss; W T Carpenter
Journal:  Arch Gen Psychiatry       Date:  1972-12

2.  Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms.

Authors:  M Harrow; L S Grossman; E S Herbener; E W Davies
Journal:  Br J Psychiatry       Date:  2000-11       Impact factor: 9.319

3.  Follow-up study of formerly hospitalized voluntary psychiatric patients: the first two years.

Authors:  S Levenstein; D F Klein; M Pollack
Journal:  Am J Psychiatry       Date:  1966-04       Impact factor: 18.112

4.  Research diagnostic criteria: rationale and reliability.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Arch Gen Psychiatry       Date:  1978-06

5.  Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome.

Authors:  A Martínez-Arán; E Vieta; F Colom; C Torrent; J Sánchez-Moreno; M Reinares; A Benabarre; J M Goikolea; E Brugué; C Daban; M Salamero
Journal:  Bipolar Disord       Date:  2004-06       Impact factor: 6.744

6.  Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial.

Authors:  Lizheng Shi; Madhav A Namjoshi; Ralph Swindle; Xiaomin Yu; Richard Risser; Robert W Baker; Mauricio Tohen
Journal:  Clin Ther       Date:  2004-01       Impact factor: 3.393

7.  Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study.

Authors:  C M Bonnín; A Martínez-Arán; C Torrent; I Pacchiarotti; A R Rosa; C Franco; A Murru; J Sanchez-Moreno; E Vieta
Journal:  J Affect Disord       Date:  2009-06-07       Impact factor: 4.839

8.  Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up.

Authors:  Joseph F Goldberg; Martin Harrow
Journal:  J Affect Disord       Date:  2004-08       Impact factor: 4.839

9.  Association between cognitive functioning and employment status of persons with bipolar disorder.

Authors:  Faith B Dickerson; John J Boronow; Cassie R Stallings; Andrea E Origoni; Sara Cole; Robert H Yolken
Journal:  Psychiatr Serv       Date:  2004-01       Impact factor: 3.084

10.  Verbal memory in mania: effects of clinical state and task requirements.

Authors:  David E Fleck; Paula K Shear; Molly E Zimmerman; Glen E Getz; Kimberly B Corey; Amy Jak; Brian K Lebowitz; Stephen M Strakowski
Journal:  Bipolar Disord       Date:  2003-10       Impact factor: 6.744

View more
  51 in total

Review 1.  Functional impairment, stress, and psychosocial intervention in bipolar disorder.

Authors:  David J Miklowitz
Journal:  Curr Psychiatry Rep       Date:  2011-12       Impact factor: 5.285

2.  Attention/processing speed prospectively predicts social impairment 18 years later in mood disorders.

Authors:  Casey Sarapas; Stewart A Shankman; Martin Harrow; Robert N Faull
Journal:  J Nerv Ment Dis       Date:  2013-09       Impact factor: 2.254

3.  Assessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design.

Authors:  Katherine E Burdick; Terence A Ketter; Joseph F Goldberg; Joseph R Calabrese
Journal:  J Clin Psychiatry       Date:  2015-03       Impact factor: 4.384

4.  Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications.

Authors:  K E Burdick; M Russo; S Frangou; K Mahon; R J Braga; M Shanahan; A K Malhotra
Journal:  Psychol Med       Date:  2014-03-11       Impact factor: 7.723

5.  [Neuropsychological Profile and Working Memory in Bipolar Disorder].

Authors:  Frédéric Coppola; Philippe Courtet; Emilie Olié
Journal:  Can J Psychiatry       Date:  2017-11-29       Impact factor: 4.356

Review 6.  Cognitive training for impaired neural systems in neuropsychiatric illness.

Authors:  Sophia Vinogradov; Melissa Fisher; Etienne de Villers-Sidani
Journal:  Neuropsychopharmacology       Date:  2011-11-02       Impact factor: 7.853

7.  Affective symptoms and intra-individual variability in the short-term course of cognitive functioning in bipolar disorder.

Authors:  C A Depp; G N Savla; L A Vergel de Dios; B T Mausbach; B W Palmer
Journal:  Psychol Med       Date:  2011-12-09       Impact factor: 7.723

8.  Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction.

Authors:  Katherine E Burdick; Raphael J Braga; Charles U Nnadi; Yaniv Shaya; Walter H Stearns; Anil K Malhotra
Journal:  J Clin Psychiatry       Date:  2011-11-29       Impact factor: 4.384

9.  Neurological soft signs and cognitive functions: Amongst euthymic bipolar I disorder cases, non-affected first degree relatives and healthy controls.

Authors:  Srikant Sharma; Triptish Bhatia; Sati Mazumdar; Smita N Deshpande
Journal:  Asian J Psychiatr       Date:  2016-04-23

10.  Equivalent linear change in cognition between individuals with bipolar disorder and healthy controls over 5 years.

Authors:  Kelly A Ryan; Shervin Assari; Kaley Angers; David F Marshall; Kristin Hinrichs; Rebecca Easter; Pallavi Babu; Bethany D Pester; Scott A Langenecker; Melvin G McInnis
Journal:  Bipolar Disord       Date:  2017-09-14       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.